Ziccum receives research grant from Vinnova AB (publ)
Ziccum has received a 200,000 SEK research grant from Vinnova AB (publ). The research grant will be used to evaluate Ziccum's method of producing vaccines in dry-powder form.The evaluation will take place in the ‘TESTA Center’ laboratories in Uppsala in premises that comply with BSL2 (Biosafety Level 2) standards, the required standard for collaboration with industrial partners on vaccine development.